Christopher I. Wright - 21 May 2025 Form 4 Insider Report for Alkermes plc. (ALKS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 May 2025, 18:01:52 UTC
Prior SEC filing
01 Jul 2024
Next SEC filing
02 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright

Key filing fact

Christopher I. Wright filed Form 4 for Alkermes plc. (ALKS) on 23 May 2025.

Key facts

  • This page summarizes Christopher I. Wright's Form 4 filing for Alkermes plc. (ALKS).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 23 May 2025, 18:01.

Change

  • Previous filing in this sequence was filed on 01 Jul 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001838503 Primary reporting owner

Wright Christopher I

Relationship
Director
Address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN
Signature
/s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
Signature date
23 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALKS transaction Derivative

Non Qualified Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+13,474
Change %
Price
$0.000000
Shares after
13,474
Date
21 May 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
13,474
Exercise price
$30.53
Footnotes
F1
ALKS transaction Derivative

Restricted Stock Unit Award

Award

Transaction value
$0
Shares
+6,142
Change %
Price
$0.000000
Shares after
6,142
Date
21 May 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,142
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares subject to the stock option award vest and become exercisable in full on 5/21/2026.

Footnote F2

Each restricted stock unit represents a contingent right to receive one ordinary share.

Footnote F3

Shares subject to the restricted stock unit award vest in full on 5/21/2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .